• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重肢体缺血患者的再入院负担。

Burden of Readmissions Among Patients With Critical Limb Ischemia.

机构信息

Department of Cardiology, Section of Interventional Cardiology, Geisinger Medical Center, Danville, Pennsylvania.

Institute for Advanced Application, Geisinger Health System, Danville, Pennsylvania.

出版信息

J Am Coll Cardiol. 2017 Apr 18;69(15):1897-1908. doi: 10.1016/j.jacc.2017.02.040. Epub 2017 Mar 6.

DOI:10.1016/j.jacc.2017.02.040
PMID:28279748
Abstract

BACKGROUND

Readmissions constitute a major health care burden among critical limb ischemia (CLI) patients.

OBJECTIVES

This study aimed to determine the incidence of readmission and factors affecting readmission in CLI patients.

METHODS

All adult hospitalizations with a diagnosis code for CLI were included from State Inpatient Databases from Florida (2009 to 2013), New York (2010 to 2013), and California (2009 to 2011). Data were merged with the directory available from the American Hospital Association to obtain detailed information on hospital-related characteristics. Geographic and routing analysis was performed to evaluate the effect of travel time to the hospital on readmission rate.

RESULTS

Overall, 695,782 admissions from 212,241 patients were analyzed. Of these, 284,189 were admissions with a principal diagnosis of CLI (primary CLI admissions). All-cause readmission rates at 30 days and 6 months were 27.1% and 56.6%, respectively. The majority of these were unplanned readmissions. Unplanned readmission rates at 30 days and 6 months were 23.6% and 47.7%, respectively. The major predictors of 6-month unplanned readmissions included age, female sex, black/Hispanic race, prior amputation, Charlson comorbidity index, and need for home health care or rehabilitation facility upon discharge. Patients covered by private insurance were least likely to have a readmission compared with Medicaid/no insurance and Medicare populations. Travel time to the hospital was inversely associated with 6-month unplanned readmission rates. There was a significant interaction between travel time and major amputation as well as travel time and revascularization strategy; however, the inverse association between travel time and unplanned readmission rate was evident in all subgroups. Furthermore, length of stay during index hospitalization was directly associated with the likelihood of 6-month unplanned readmission (odds ratio for log-transformed length of stay: 2.39 [99% confidence interval: 2.31 to 2.47]).

CONCLUSIONS

Readmission among patients with CLI is high, the majority of them being unplanned readmissions. Several demographic, clinical, and socioeconomic factors play important roles in predicting readmissions.

摘要

背景

再入院是 CLI 患者的主要医疗负担。

目的

本研究旨在确定 CLI 患者的再入院发生率及影响再入院的因素。

方法

从佛罗里达州(2009 年至 2013 年)、纽约州(2010 年至 2013 年)和加利福尼亚州(2009 年至 2011 年)的州住院患者数据库中纳入所有诊断为 CLI 的成年住院患者。将数据与美国医院协会的名录合并,以获取有关医院相关特征的详细信息。进行地理和路径分析,以评估到医院的旅行时间对再入院率的影响。

结果

总体而言,分析了 212241 例患者的 695782 例入院。其中,284189 例为 CLI 的主要诊断(主要 CLI 入院)。30 天和 6 个月的全因再入院率分别为 27.1%和 56.6%。其中大多数为非计划性再入院。30 天和 6 个月的非计划性再入院率分别为 23.6%和 47.7%。6 个月非计划性再入院的主要预测因素包括年龄、女性、黑人和/或西班牙裔、既往截肢、Charlson 合并症指数以及出院时需要家庭保健或康复设施。与 Medicaid/无保险和 Medicare 人群相比,私人保险覆盖的患者再入院的可能性最低。到医院的旅行时间与 6 个月的非计划性再入院率呈负相关。旅行时间与主要截肢以及旅行时间与血运重建策略之间存在显著交互作用;然而,旅行时间与非计划性再入院率之间的负相关在所有亚组中均存在。此外,指数住院期间的住院时间与 6 个月非计划性再入院的可能性直接相关(对数转换住院时间的优势比:2.39[99%置信区间:2.31 至 2.47])。

结论

CLI 患者的再入院率很高,其中大多数为非计划性再入院。几个人口统计学、临床和社会经济因素在预测再入院方面起着重要作用。

相似文献

1
Burden of Readmissions Among Patients With Critical Limb Ischemia.严重肢体缺血患者的再入院负担。
J Am Coll Cardiol. 2017 Apr 18;69(15):1897-1908. doi: 10.1016/j.jacc.2017.02.040. Epub 2017 Mar 6.
2
Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia.全国范围内间歇性跛行和严重肢体缺血患者再入院因素
Ann Vasc Surg. 2018 Oct;52:96-107. doi: 10.1016/j.avsg.2018.03.011. Epub 2018 May 17.
3
Readmissions to an alternate hospital in patients undergoing vascular intervention for claudication and critical limb ischemia associated with significantly higher mortality.跛行和严重肢体缺血行血管介入治疗的患者在另一家医院的再入院与显著更高的死亡率相关。
J Vasc Surg. 2019 Dec;70(6):1960-1972. doi: 10.1016/j.jvs.2019.02.055. Epub 2019 May 29.
4
Risk factors for 30-day unplanned readmission following infrainguinal endovascular interventions.股下血管腔内介入治疗后30天内非计划再入院的危险因素。
J Vasc Surg. 2017 Feb;65(2):484-494.e3. doi: 10.1016/j.jvs.2016.08.093.
5
Unplanned readmissions after endovascular intervention or surgical bypass for critical limb ischemia.血管内介入治疗或手术旁路治疗肢体严重缺血后的非计划性再入院。
J Vasc Surg. 2021 Mar;73(3):942-949.e1. doi: 10.1016/j.jvs.2020.07.096. Epub 2020 Aug 27.
6
Six-month readmissions after bariatric surgery: Results of a nationwide analysis.减重手术后 6 个月的再入院率:一项全国性分析的结果。
Surgery. 2019 Nov;166(5):926-933. doi: 10.1016/j.surg.2019.06.003. Epub 2019 Aug 6.
7
Predictive factors of 30-day unplanned readmission after lower extremity bypass.下肢旁路术后 30 天内非计划性再入院的预测因素。
J Vasc Surg. 2013 Apr;57(4):955-62. doi: 10.1016/j.jvs.2012.09.077. Epub 2013 Jan 17.
8
Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost: Insights From the Nationwide Readmission Database.美国 833344 例经皮冠状动脉介入治疗后 30 天再入院负担:预测因素、原因和费用:来自全国再入院数据库的见解。
JACC Cardiovasc Interv. 2018 Apr 9;11(7):665-674. doi: 10.1016/j.jcin.2018.01.248.
9
Coronary artery bypass graft readmission rates and risk factors - A retrospective cohort study.冠状动脉旁路移植术再入院率及危险因素:一项回顾性队列研究。
Int J Surg. 2018 Jun;54(Pt A):7-17. doi: 10.1016/j.ijsu.2018.04.022. Epub 2018 Apr 17.
10
Factors associated with unplanned readmissions in a major Australian health service.澳大利亚一家大型医疗服务机构中与非计划再入院相关的因素。
Aust Health Rev. 2019 Feb;43(1):1-9. doi: 10.1071/AH16287.

引用本文的文献

1
Acute Limb Ischemia After Percutaneous Coronary Intervention for Stable Coronary Artery Disease.稳定型冠状动脉疾病经皮冠状动脉介入治疗后急性肢体缺血
J Am Heart Assoc. 2025 May 6;14(9):e040026. doi: 10.1161/JAHA.124.040026. Epub 2025 Apr 23.
2
Emerging Strategies for Revascularization: Use of Cell-Derived Extracellular Vesicles and Artificial Nanovesicles in Critical Limb Ischemia.血管重建的新兴策略:细胞衍生的细胞外囊泡和人工纳米囊泡在严重肢体缺血中的应用
Bioengineering (Basel). 2025 Jan 20;12(1):92. doi: 10.3390/bioengineering12010092.
3
Endothelial Progenitor Cells May Be Related to Major Amputation after Angioplasty in Patients with Critical Limb Ischemia.
内皮祖细胞可能与严重肢体缺血患者血管成形术后大截肢有关。
Cells. 2023 Feb 11;12(4):584. doi: 10.3390/cells12040584.
4
Comparison of 6-Month Outcomes of Endovascular vs Surgical Revascularization for Patients With Critical Limb Ischemia.血管内治疗与手术血运重建治疗肢体严重缺血患者的 6 个月结局比较。
JAMA Netw Open. 2022 Aug 1;5(8):e2227746. doi: 10.1001/jamanetworkopen.2022.27746.
5
Racial and ethnic disparities in 3-year outcomes following infrainguinal bypass for chronic limb-threatening ischemia.慢性肢体严重缺血患者行腘动脉以下旁路手术后 3 年结局的种族和民族差异。
J Vasc Surg. 2022 Nov;76(5):1335-1346.e7. doi: 10.1016/j.jvs.2022.06.026. Epub 2022 Jun 26.
6
Hemodialysis Vascular Access and Risk of Major Bleeding, Thrombosis, and Cardiovascular Events: A Cohort Study.血液透析血管通路与大出血、血栓形成及心血管事件风险:一项队列研究
Kidney Med. 2022 Mar 24;4(6):100456. doi: 10.1016/j.xkme.2022.100456. eCollection 2022 Jun.
7
Orthopedic Surgery Referral Pattern Analysis per Demographic Factors Among Patients Diagnosed With Severe Peripheral Artery Disease in Terms of Partial or Total Limb Amputation.根据人口统计学因素对确诊为严重外周动脉疾病且有部分或全部肢体截肢情况的患者进行骨科手术转诊模式分析。
Cureus. 2022 Jan 20;14(1):e21455. doi: 10.7759/cureus.21455. eCollection 2022 Jan.
8
Geographic Disparities in Readmissions for Peripheral Artery Disease in South Carolina.南卡罗来纳州外周动脉疾病再入院的地域差异。
Int J Environ Res Public Health. 2021 Dec 28;19(1):285. doi: 10.3390/ijerph19010285.
9
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID.心力衰竭与外周动脉疾病患者结局的相关性:EUCLID 的见解。
J Am Heart Assoc. 2021 Jun 15;10(12):e018684. doi: 10.1161/JAHA.120.018684. Epub 2021 May 31.
10
In vitro recellularization of decellularized bovine carotid arteries using human endothelial colony forming cells.使用人内皮祖细胞对去细胞牛颈动脉进行体外再细胞化。
J Biol Eng. 2021 Apr 21;15(1):15. doi: 10.1186/s13036-021-00266-5.